DENTSPLY SIRONA Inc. ($XRAY) Stock Forecast: Up 2.4% Today

What is DENTSPLY SIRONA Inc.?

Dentsply Sirona (NYSE: XRAY) is the world's largest diversified manufacturer of dental products. Today, the stock XRAY experienced a strong bullish movement in the market.

Why is DENTSPLY SIRONA Inc. going up?

XRAY stock is up 2.4% on Dec 10, 2025 16:00

• The bullish movement in XRAY stock could be attributed to the lease renewal at Hobbs Brook Real Estate's Waltham Campus, securing Dentsply Sirona's occupancy as the sole occupant until 2032. This highlights the company's commitment to its facilities and operations.
• Despite initiating coverage on Dentsply Sirona with an Underweight rating and a price target below its current value, the market seems to have reacted positively to the long-term lease renewal news, showcasing investor confidence in the company's future prospects.
• The extension of the lease in Waltham through 2032 provides stability and continuity for Dentsply Sirona's regional office presence, potentially reassuring investors and contributing to the bullish momentum in the stock price.

XRAY Price Chart

XRAY Technical Analysis

XRAY News

Dentsply Sirona Extends Lease at Hobbs Brook Real Estate’s Waltham Campus Through 2032

Dentsply Sirona (NYSE: XRAY), the world’s largest diversified manufacturer of dental products, has renewed its lease for 84,413 square feet at 590 Lincoln Street, part of Hobbs Brook Real Estate’s Waltham Campus. This six-year extension secures Dentsply Sirona's tenancy as the sole occupant of the facility through 2032, highlighting the strength of the partnership between the two companies. The building offers both manufacturing and office space within a campus known for community, connectivity, and sustainability features, located conveniently near Boston.

https://bostonrealestatetimes.com/dentsply-sirona-extends-lease-at-hobbs-brook-real-estates-waltham-campus-through-2032/

Barclays Initiates Coverage on Dentsply Sirona (XRAY) with Underweight Rating

Barclays has initiated coverage on Dentsply Sirona (XRAY) with an Underweight rating and a price target of $12.00 USD. This new rating comes amidst various recent analyst evaluations, with an average target price of $12.73 from 13 analysts, suggesting a 13.82% upside from its current price. Dentsply Sirona, a major dental equipment manufacturer, currently holds an average brokerage recommendation of "Hold" and an estimated GF Value of $27.58.

https://www.gurufocus.com/news/3239556/barclays-initiates-coverage-on-dentsply-sirona-xray-with-underweight-rating-xray-stock-news

Manufacturer signs lease renewal in Waltham through 2032

Dentsply Sirona, a dental technologies and products manufacturer, has renewed its lease for 84,000 square feet at 590 Lincoln St. in Waltham. The renewal extends their occupancy in the office building through 2032. This secures the regional office presence for the company in Waltham for another seven years.

https://www.bizjournals.com/boston/news/2025/12/03/dentsply-sirona-renews-waltham-lease-through-2032.html

Trending Today

Filecoin ($FIL) Crypto Forecast: Up 5.0% Today

PancakeSwap ($CAKE) Crypto Forecast: Down 5.1% Today

Silver ($XAG) Commodity Forecast: Up 5.0% Today

Beyond Meat Inc. ($BYND) Stock Forecast: Up 5.7% Today

Comcast Corporation Class A Common Stock ($CMCSA) Stock Forecast: Up 5.0% Today

National Oilwell Varco Inc. ($NOV) Stock Forecast: Down 5.1% Today

Phillips 66 ($PSX) Stock Forecast: Down 5.1% Today

Pfizer Inc. ($PFE) Stock Forecast: Down 5.1% Today

Humana Inc. ($HUM) Stock Forecast: Down 5.1% Today

Cytokinetics, Incorporated ($CYTK) Stock Forecast: Down 5.0% Today

DENTSPLY SIRONA Inc. Price History

09.04.2025 - XRAY Stock was up 5.3%

• Following the release of its Q1 earnings report, XRAY stock experienced a strong bullish movement.
• The company reported better-than-expected earnings per share (EPS) of $0.43, surpassing the $0.30 estimate, and exceeded revenue expectations with sales of $879 million.
• Despite a slight decrease in gross margin, Dentsply Sirona's performance in the face of global macroeconomic challenges impressed investors, resulting in a surge in the stock price.
• The company raised its FY25 sales guidance to $3.60 billion-$3.70 billion and reaffirmed the EPS range of $1.80-$2.00, boosting investor confidence in its future prospects and driving the bullish market movement.

10.09.2025 - XRAY Stock was down 5.2%

• Potential concerns or uncertainty arose among investors in response to the upcoming investor conference call scheduled for November 6th, prompting a sell-off of XRAY shares.
• Investors may be expecting unfavorable financial results to be addressed during the call, leading to a negative market reaction.
• The absence of positive developments or announcements may have influenced the bearish sentiment surrounding XRAY today.

08.04.2025 - XRAY Stock was up 17.4%

• XRAY stock saw a significant bullish movement following the company's impressive Q1 earnings and revenue beat.
• Despite a slight decrease in gross margin, investors were encouraged by DENTSPLY SIRONA's customer-centric innovation and operational efficiency, which contributed to its strong performance in the face of global macroeconomic challenges.
• The market reacted positively to the company's ability to navigate the challenging economic environment, showing confidence in its long-term growth prospects.

11.11.2024 - XRAY Stock was up 5.2%

• The bullish movement in XRAY stock could be attributed to investors finding reasons to retain Dentsply Sirona stock in their portfolios despite the ongoing challenges.
• The pending securities fraud class action lawsuit may have initially caused some uncertainty and volatility in the stock price, but investors seem to have gained confidence in the company's product portfolio.
• Despite the deadline alerts reminding investors of potential losses, the stock managed to have a strong bullish movement, indicating that some positive news or developments might have overshadowed these concerns.
• Overall, the market movement suggests that investors are focusing more on the company's product traction and potential growth rather than the pending legal issues and macroeconomic challenges.

21.04.2025 - XRAY Stock was down 5.0%

• The news about Dentsply Sirona's involvement in an upcoming conference did not generate enthusiasm among investors, resulting in a downward trend in XRAY stock.
• Investors may be anticipating more substantial developments or announcements from the company beyond conference participation.
• The limited positive market reaction suggests investors are looking for concrete progress or growth opportunities from Dentsply Sirona to boost the stock price.

14.00.2025 - XRAY Stock was down 0.9%

• The decline in XRAY's stock price is potentially linked to ongoing securities class action lawsuits against the company.
• Investor sentiment appears to be negative due to concerns over legal uncertainties, prompting a sell-off of XRAY shares.
• There is a looming deadline for investors to secure counsel by January 27, 2025, which may be further impacting the stock price.
• Overall, market sentiment towards XRAY is bearish as investors assess the potential implications of the legal proceedings on the company's financial performance and reputation.

10.11.2025 - XRAY Stock was up 2.4%

• The bullish movement in XRAY stock could be attributed to the lease renewal at Hobbs Brook Real Estate's Waltham Campus, securing Dentsply Sirona's occupancy as the sole occupant until 2032. This highlights the company's commitment to its facilities and operations.
• Despite initiating coverage on Dentsply Sirona with an Underweight rating and a price target below its current value, the market seems to have reacted positively to the long-term lease renewal news, showcasing investor confidence in the company's future prospects.
• The extension of the lease in Waltham through 2032 provides stability and continuity for Dentsply Sirona's regional office presence, potentially reassuring investors and contributing to the bullish momentum in the stock price.

27.01.2025 - XRAY Stock was down 5.6%

• The bearish movement in XRAY's stock today could be attributed to the tough fourth-quarter performance.
• Factors such as revenue loss from Byte, weak demand for U.S. equipment, and implant pressures may have contributed to investor concerns and selling pressure on the stock.
• Investors may be reacting to the potential impact of these challenges on XRAY's financial performance and future prospects, leading to the bearish movement in the stock today.

22.06.2025 - XRAY Stock was up 5.2%

• The appointment of Daniel Scavilla as the new Chief Executive Officer of Dentsply Sirona appears to have boosted investor confidence, given his significant background in the medical technology and pharmaceutical sectors, potentially leading to positive changes within the company.
• The company's upbeat preliminary results for the second quarter and reaffirmation of its 2025 outlook likely played a role in the bullish movement, indicating robust performance and consistency.
• Investor sentiment might have been further bolstered by the company's advancements in digital implants, research and development capabilities, as well as margin growth despite facing challenges in certain markets, highlighting reasons to consider adding Dentsply Sirona stock to portfolios.

08.07.2025 - XRAY Stock was down 5.4%

• Despite beating earnings and revenue estimates, XRAY experienced a bearish movement likely due to revenue declines and ongoing weakness in the U.S. market.
• The positive impact of Imaging strength and SureSmile growth on Q2 performance was overshadowed by the drag from Byte's performance and macroeconomic pressures.
• Investors may have reacted negatively to the mixed results, leading to the bearish movement in XRAY stock today.

06.10.2025 - XRAY Stock was down 10.5%

• XRAY stock faced a significant decline following a Q3 earnings miss and a downward revision in its 2025 EPS outlook, impacting investor sentiment.
• Persistent softness in U.S. demand and orthodontic segments, despite sound cost management, may be contributing to the downturn in XRAY stock.
• The combination of missing earnings projections, lowered EPS guidance, and concerns regarding segment performance has likely precipitated the notable drop in XRAY stock price.

06.10.2025 - XRAY Stock was down 13.5%

• XRAY's stock price decline may be linked to investor concerns about underwhelming Q3 earnings.
• Weak U.S. demand and orthodontic segments have possibly sparked worries about the company's revenue and growth prospects.
• Even with consistent cost management, persistent challenges in key segments revealed in the Q3 results could be contributing to XRAY's current bearish trend.